Check out all the latest photos from FIS Maastricht.
Fiduciary Investors Symposium
Impact investing’s case for scale
Impact investing has come a long way in the past two decades, going from a niche strategy to a $1.5 trillion industry, but there are still challenges for it to reach institutional scale due to the lack of products and insufficient evidence of outperformance in some parts of the market.
Sort content by
What it means if ‘DNA is not destiny’
Geneticist David Sinclair says aging is a disease and it is preventable and treatable. He told the Fiduciary Investors Symposium that research demonstrates we can slow down or even reverse the aging process. It sounds like good news, but the consequences for society and the investment community are profound.
FIS Harvard 2025: Photo gallery
Explore our photo gallery from FIS Harvard, May 19-21, 2025.
Investors reflect on whether active managers can escape the Magnificent 7
Active managers has been under stress for several years due to lukewarm performance commonly attributed to the rise and rise of large cap technology stocks and passive investing. However, investors at the Top1000funds.com Fiduciary Investors Symposium concluded that the root cause of that stress might be more complicated.
Path to net zero requires honest dialogue about sustainable investing
Leading institutional investors at the Fiduciary Investors Symposium at Harvard said the industry could benefit from having a franker conversation about sustainable investments, both in terms of what climate goals are achievable on the path to net zero and what is behind the pushback on ESG funds.
CPPIB spots accelerating change, alpha opportunities in healthcare
Technology is reshaping the healthcare sector, creating opportunities that investors “never imagined” as companies apply robotics and AI to new and established treatments.
TPA: Unlocking alpha through enhanced liquidity management
Stronger liquidity management through a total portfolio approach (TPA) can do more than manage real-time risk exposures – it can also help generate alpha, according to panellists at the Fiduciary Investors Symposium at Harvard University.
Leave a Comment
You must be logged in to post a comment.
Login